SCHEMBL19681644

SCHEMBL19681644

CCCCCCCCC(CN(CCC(=O)NCC[N+](C)(C)CCCS(=O)(=O)[O-])CCN(CCN(CC(CCCCCCCC)OC(C)=O)CC(CCCCCCCC)OC(C)=O)CCN(CC(CCCCCCCC)OC(C)=O)CC(CCCCCCCC)OC(C)=O)OC(C)=O

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.32
LMNA P02545 1/20 0.32
POLB P06746 1/20 0.32
GRK2 P25098 1/20 0.32
KMT2A Q03164 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
DNM1 Q05193 2/20 0.32
MAPT P10636 1/20 0.31
ADRA1D P25100 1/20 0.31
PTAFR P25105 1/20 0.31
HTR1D P28221 1/20 0.31
HTR2C P28335 1/20 0.31
ADRA1B P35368 1/20 0.31
DRD3 P35462 1/20 0.31
TMEM97 Q5BJF2 1/20 0.31
BBOX1 O75936 1/20 0.31
EPHX2 P34913 1/20 0.31
TRPV1 Q8NER1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24787485 0.92 DNM1 (0.33) DNM1MAPTEPHX2TRPV1
SCHEMBL19681645 0.87 FAAH (0.35) MEN1LMNAPOLBGRK2KMT2A
SCHEMBL21965331 0.86 DNM1 (0.34) MEN1LMNAPOLBGRK2KMT2A
SCHEMBL19681591 0.85 BBOX1 (0.39) MEN1LMNAPOLBGRK2KMT2A
SCHEMBL25681904 0.84 TLR2 (0.40) MEN1LMNAKMT2ADNM1MAPT
SCHEMBL24787484 0.84 TLR2 (0.40) MEN1LMNAKMT2ADNM1MAPT
SCHEMBL24787486 0.83 DNM1 (0.31) DNM1
SCHEMBL19681581 0.79 ADRA1D (0.37) MAPTADRA1DPTAFRHTR1DHTR2C
SCHEMBL25681831 0.78 FAAH (0.36) L3MBTL1DNM1EPHX2
SCHEMBL30511241 0.78 BBOX1 (0.45) DNM1ADRA1DPTAFRHTR1DHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11685710-B2 Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2023-06-27 US disclosed
US-20210395192-A1 CATIONIC SULFONAMIDE AMINO LIPIDS AND AMPHIPHILIC ZWITTERIONIC AMINO LIPIDS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2021-12-23 US disclosed
US-10562849-B2 Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2020-02-18 US disclosed
US-20170349543-A1 CATIONIC SULFONAMIDE AMINO LIPIDS AND AMPHIPHILIC ZWITTERIONIC AMINO LIPIDS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2017-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170349543-A1 CATIONIC SULFONAMIDE AMINO LIPIDS AND AMPHIPHILIC ZWITTERIONIC AMINO LIPIDS ABHD16A, AARS1, CFTR MEN1 2129/4885LMNA 2073/4885POLB 1641/4885
US-10562849-B2 Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids ABHD16A, AARS1, CFTR MEN1 2129/4885LMNA 2073/4885POLB 1641/4885
US-11685710-B2 Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids ABHD16A, AARS1, CFTR MEN1 2129/4885LMNA 2073/4885POLB 1641/4885
US-20210395192-A1 CATIONIC SULFONAMIDE AMINO LIPIDS AND AMPHIPHILIC ZWITTERIONIC AMINO LIPIDS ABHD16A, AARS1, CFTR MEN1 2129/4885LMNA 2073/4885POLB 1641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.